Literature DB >> 8165725

Protein kinase C: is its pivotal role in cellular activation over-stated?

S E Wilkinson1, T J Hallam.   

Abstract

Evidence has emerged over the past decade to suggest that protein kinase C (PKC) is a widespread family of kinases responsible for many diverse and critical cellular functions. With the development of selective agents to activate or inhibit the individual PKC isoenzymes, it is now apparent that much of the literature that implicated PKC in many cellular functions needs to be appraised. In this article, Sandra Wilkinson and Trevor Hallam discuss the problems of the existing methods and the recent evidence that suggests that PKC isotypes are necessary for some, but not all, of those cellular responses where PKC had been thought to play an important role. Selective inhibitors of PKC isoenzymes may have potential for therapeutic use in auto-immune diseases, transplant rejection and oncology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165725     DOI: 10.1016/0165-6147(94)90110-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  21 in total

1.  Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep3B cells.

Authors:  S L Hsu; Y H Chou; S C Yin; J Y Liu
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

2.  Phorbol 12-myristate 13-acetate down-regulates Na,K-ATPase independent of its protein kinase C site: decrease in basolateral cell surface area.

Authors:  J Beron; I Forster; P Beguin; K Geering; F Verrey
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

3.  Inhibition by adenosine A(2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons.

Authors:  K Wirkner; H Assmann; L Köles; Z Gerevich; H Franke; W Nörenberg; R Boehm; P Illes
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Regulation of neuregulin expression in the injured rat brain and cultured astrocytes.

Authors:  Y Tokita; H Keino; F Matsui; S Aono; H Ishiguro; S Higashiyama; A Oohira
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

5.  1-O-Octadecyl-2-O-methylglycerophosphocholine inhibits protein kinase C-dependent phosphorylation of endogenous proteins in MCF-7 cells.

Authors:  X Zhou; G Arthur
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

6.  Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts.

Authors:  N J Jordan; M L Watson; T Yoshimura; J Westwick
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

8.  Intracellular cross-talk between thyrotropin receptor and A1 adenosine receptor in regulation of phospholipase C and adenylate cyclase in COS-7 cells transfected with their receptor genes.

Authors:  F Okajima; H Tomura; K Sho; M Akbar; M A Majid; Y Kondo
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

9.  Inhibition by hydroxyachillin, sesquiterpene lactone from Tanacetum microphyllum, of PMA-induced mouse ear oedema.

Authors:  A M Silván; M J Abad; P Bermejo; A Villar
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

10.  Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.

Authors:  N M Dean; R McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.